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CHAPTER 1: INTRODUCTION
Definition of the Problem
According to Evans et al. (1990), the mare is regarded as having a low
reproductive efficiency because many mares that have successful performance records
are kept as broodmares without consideration to existing reproductive problems.
Reproduction in the mare is a complex process, unique in many ways, including the
anatomical site of ovulation, follicular growth patterns, long estrous periods,
differentiation of fertilized and nonfertilized ova, and equine chorionic gonadotropin
(eCG) secretion in pregnant mares.
Progestin production in the mare is critical for the maintenance of pregnancy. For
example, progesterone (P4) plays an essential role in placentation, embryo development,
and placental functions. Profiling progestins, such as P4, in mid-gestation could be
indicative of fetal well being and a successful pregnancy to term. Determining the time
period when certain progestins increase rapidly might reflect pregnancy maintenance by
the placenta. This information may allow for the development of diagnostic tests to
measure the concentration of those particular progestins. Their determination may
preclude exogenous progestin therapy. Exogenous progestin therapy is administered to
ensure P4 levels are above 2 ng/ml (an adequate level for pregnancy maintenance).
Detecting progestins in both plasma and feces could be useful in reproductive studies of
feral horses. For instance, if the same progestins correlate in concentration in both
sources, only one sample would be necessary to obtain valid results.
Statement of Purpose
Aims of this research were to determine the time period and specific progestins
reflective of the transition from ovarian source to the placental source of progestins in2
mare plasma and feces using a spline regression; to describe an accurate profile of total
and individual progestins found in plasma and fecal samples taken every other day from
64 to 150 days of gestation; to correlate individual plasma to fecal progestins over time;
and to see if certain plasma and fecal progestins increased around 90 days of gestation
similarly to urinary hormones, estrone sulfate (E1S) and pregnanediol glucuronide (PdG)
(Riad and Holtan, 1993).
In one study by Heistermann et al. (1996), excretion patterns of estrogens and
progestins in feces were highly correlated with those in urine throughout gestation in
bonobos, but fecal steroids showed a lesser increase. Measuring E1S and PdG in urine
was used to assess ovarian cycles since they reflected the changes in corresponding
circulatory hormones in primates. That study found fecal P4 and PdG were significantly
correlated with urinary PdG concentrations; therefore, measuring either steroid in feces
could reliably monitor corpora lutea (CL) function.
On the contrary, the study by Sist et al. (1987) showed there was no correlation
between plasma and fecal values of El S in the mare. Despite these findings, our studies
will measure plasma and fecal progestin concentrations, and compare them to urinary
E1S and PdG levels.3
CHAPTER 2: LITERATURE REVIEW
Overview
Reproductive physiology and endocrinology of mares is similar to other domestic
animals in some aspects, but quite different in other ways. A complete review of
reproduction and endocrinology in the mare can be found in the 1992 edition of
Reproductive Biology in the Mare by O.J. Ginther. A complete review of reproduction
and endocrinology of other domestic animals is located in Reproduction in Farm Animals
by E.S.E. Hafez (1993). These features, along with exogenous hormone treatment in the
mare, will be discussed.
Ovarian Anatomy and Function
Ovaries are considered to be unique endocrine and exocrine glands, and essential
organs in reproduction and pregnancy. The inside of ovaries is composed of connective
tissue, fofficles, and CL that are in varying stages of development or regression during the
breeding season or pregnancy. Follicles not confined to a particular area or outer layer,
as in other animals, are distributed throughout the ovary. Follicles are classified as
primordial, growing, or Graafian. Primordial follicles consist of an oocyte surrounded by
the zona pellucida. As one or more primordial follicles develop, they become surrounded
by several layers of granulosa cells and are referred to as growing follicles. These types
of follicles continue to develop into Graafian or dominant follicles (Evans et aL, 1990).
Future dominant follicles have an early size advantage over future subordinate follicles
(Gastal et al., 1997).
As follicles increase in size and develop, they migrate to the ovulation fossa.
Rupturing of these follicles is spontaneous with the follicular wall collapsing into the
follicular cavity, along with hemorrhage from the thecal capillaries. Granulosa cellsundergo luteinization, and theca intema cells invade granulosa walls (Evans et al.,
1990), resulting in a structure known as the primary CL.
Recent research suggests that in the pregnant mare, the primary CL becomes the
sole source of P4 maintaining pregnancy for the first 70 to 90 days (Discafani et al.,
1995; Albrecht et al., 1997). On the contrary, Allen (1980) stated that most primary CL
activity declines 12 to 14 days post-ovulation. Large secondary follicles develop
between 28 to 51 days of gestation, mature, ovulate, and form secondary CL that produce
maximal levels of P4 around 55 to 80 days of gestation (Squires and Ginther, 1975;
Knowles et al., 1993). The mean concentration of P4 at that time is from 14.9 to 31.9
ng/ml (Schwab et al., 1990). Martin et al. (1989) also found that plasma P4
concentrations correlate to total luteal mass.
Formations of accessory CL in pregnant mares are maximal in the second and
third month of gestation (Evans et al., 1990). Martin et al. (1989) noted that two-thirds of
secondary CL form from luteinization of unruptured follicles.
In pregnant mares, follicular development begins to wane in early gestation.
Knowles et al. (1994) found no follicles greater than 29 mm in intact mares after 100
days of gestation, and no follicles greater than 19 mm at 148 days of pregnancy. All
secondary CL were progressively smaller from 100 to 160 days of gestation (the mean
number of CL was 11 on day 100 of gestation, and 14.6 between 100 to 160 days of
pregnancy). Mean day of peak accessory CL identification was around 121.2 days of
gestation, while by 160 days of gestation, the mean number of secondary CL identified
was 10. Most accessory CL generally regress around 140 to 210 days of gestation
(Knowles et al., 1993). In addition, Daels et al. (1998) stated that secondary CL do not
develop in all pregnant mares, and their development in time and numbers are extremely
variable, indicating they may not be important in the outcome of pregnancy.
After each secondary ovulation, plasma progestagen concentrations increase and
as many as 10 to 15 additional luteal structures are present by day 120 to 150 of gestation
before degeneration occurs. At this stage, the placenta is well developed and maintains
the function of progestagen production. However, a slight decrease in serum progestagen
concentrations may occur by day 90 of pregnancy due to degeneration of secondary CL
before the placenta has completely taken over hormone production (van Niekerk and van5
Niekerk, 1 998a). In addition, increased estrogen secretion coinciding with eCG
secretion is consistently associated with the presence of active CL and vice-versa
between days 35 to 50 of pregnancy (Daels et al., 1991 a).
According to Discafam et al. (1995), the number of accessory CL was not
dependent on the day of gestation. Holtan et al. (1979) noted there was no apparent
relationship between the side of placentation, locations, and numbers of accessory CL. It
was impossible to differentiate between primary and secondary CL, since most accessory
CL regressed by day 200 of pregnancy. However, CL in mares were functional long after
they were necessary to maintain pregnancy. This could be due to individual variations in
follicular dynamics, eCG concentrations in the blood, and differences in secretion of
other reproductive hormones in mares during pregnancy. It is postulated that secondary
CL remained in the ovaries of pregnant mares longer than necessary as a fail-safe
mechanism to help ensure a successful outcome of pregnancy (Discafani et al., 1995).
Description of Progestins and Progestagens in the Mare
Certain progestins seem to be necessary for maintaining pregnancy in the mare,
altering ionic permeability across myometrial muscle cell membranes, increasing the
resting membrane potential, and lowering cellular conduction and excitability (Peariman,
1948). Most progestins also serve as precursors for other steroids. Plasma progestins
reflect physiological activity of the placenta and fetus since P4 is not present in
significant amounts in mid- to late gestation in the feto-placental circulation. As P4
decreases during the second half of pregnancy, relaxin reduces uterine contractility.
There may be other progestagens present that are biologically active in suppressing
uterine activity to prevent abortion (Short, 1959).
Predominant steroids in mare plasma in late gestation are 20a-Scx and a-diol,
and are found in high concentrations of 2000 to 2400 ng/ml and 100 to 350 nglml
respectively (Holtan etal.,1991). They are first detected between 30 to 60 days of
gestation, increasing gradually, and reaching highest levels 30 days prior to parturition
(Holtan et al., 1975; 1991). Burns and Fleeger (1975) found that total plasma
progestagens increased to 25 ng/ml at 90 days before parturition and then to 60 ng/ml 10days prior to birth, dropping to 58 ng/ml less than 5 days pre-partum. Holtan et al.
(1991) stated that 5a-DHP and 3-5a are of maternal origin, and are related to CL
function since they both follow a pattern similar to P4 in early pregnancy. It is not until
late in gestation when they are both produced by the feto-placental unit. Both 5a-DHP
and 33-5a have a rather slow, constant increase the last third of gestation, with a rapid
increase the last 20 days of gestation. Progestin 5a-DHP concentration in maternal
plasma in late pregnancy is similar to P4 concentration in early pregnancy (Pashen and
Allen, 1979a). However, when 5a-DHP increases around 50 to 70 days of gestation and
P4 decreases around that time, this suggests initiation of placental steroid production
(Burns and Fleeger, 1975). Progestin 5u-DHP is known as a potent androgen and acts
via testosterone receptors in the fetal prostate (Short, 1959), and is of placental origin
(Pashen and Allen, 1979a); it can also act via P4 receptors derived from the feto-placental
unit (Short, 1959). Its values were found to be much higher in Thoroughbred mares than
in ponies, implying genetic differences between different breeds of horses in the quantity
of P4 metabolites (Hamon et al., 1991). Plasma concentration of progestins was found to
be higher in mares carrying twins than in those carrying single foals (Morgenthal and van
Niekerk, 1991). Holtan et al. (1991) determined that no 5f3-pregnanes, 20u- and 203-
hydroxy-4-pregnen-3-one could be detected in plasma throughout gestation. In sheep,
20a- and 20-hydroxy-4-pregnen-3-one were detected, but not so in mare plasma (Miller
and Holtan, 1997).
According to Holtan et al. (1991), the differential in progestin quality and quantity
throughout pregnancy in equids most likely represented different sources and/or
metabolic pathways. Miller and Holtan (1997) stated that due to high steroid
concentrations (10 to 100 times higher in feces than in plasma), and a greater diversity of
steroids (15 to 19 progestins in feces versus 10 to 12 progestins in plasma), only a
selected few could be useful in determining placental function.7
Description of Estrogens in the Mare
Estrogens are important in priming uterine tissues prior to labor and lactogenesis
in the mare. Estrogens cause a tense uterine tone in early pregnancy between 10 to 50
days of gestation (Berg and Ginther, 1978). Estrogens have been found to stimulate
oxytocin (OT) receptors in the sheep uterus, and help with distribution and rate of blood
flow through uterine and placental blood vessels (Pashen and Allen, 1979b). Estrogens
of conceptal origin are key factors in regulating carbohydrate and amino acid flux from
the maternal system into the uterine lumen and conceptus. This mechanism assures a
continuous source of nutrition in the pre-attachment period (Zavy et al., 1984).
There have been eight estrogens isolated from urine, the predominant being
estrone (E1), equilin, and equilenin (Cox, 1975). When they were identified by Nett et al.
(1973), radioimmunoassays (RIAs) showed cross-reactions between estradiol(Ei713)and
other estrogens. The most abundant steroid hormones in plasma of pregnant mares areE1
and equilin, which increase dramatically at the same time as hypertrophy of steroidogenic
tissues in fetal gonads occurs (Merchant-Larios, 1979). Equilin plateaus after 180 days
of gestation and is <100 ng/ml in plasma. Equilin has less biological activity than E1, and
is more active than equilenin. The 173-hydroxy derivative of equilin is never found in
urine (Cox, 1975). Daels et al. (1991a) stated that E173 is the most potent of all
estrogens, but is found in low concentrations in circulation as compared toE1.
MeasuringE1in serum and plasma is a good indicator of fetal viability after 44
days of gestation. Normally,E1concentration increases between 34 to 40 days of
pregnancy in serum and urine, and is predominantly secreted by the fetus and fetal
membranes (Kasman et al., 1988). Lasley et al. (1990) also determined that measuring
estrogen conjugates (EC) after 70 days of gestation was a direct test to determine
pregnancy, since estrogens increase between 70 to 150 days parallel to fetal development.
On the other hand, Monfort et al. (1991) did a study with Przewalski horses and
determined that an increase in urinary excretion of EC around 6 weeks of gestation
indicated established pregnancy, and did not actually reflect fetal presence and viability
until endometrial cup production ceased around 90 days of gestation. If fetal death
occurred, endometrial cups would continue producing eCG.According to Jeffcott et al. (1987), there was a rise in total estrogens of
ovarian origin between 35 to 40 days of gestation, and high E1S concentrations were
present due to a sulfo-transferase system in the endometrium of the pregnant mare. The
ovary itself contributes significantly to EC concentrations between 20 to 70 days of
gestation, while increasing levels at 33 to 39 days are due to the change in rate of ovarian
estrogen synthesis (Daels et al., 1990).
Endometrial Cups in the Mare
Endometrial cups are a striking feature of equine pregnancy. These small, ulcer-
like, endometrial outgrowths are formed between 36 to 38 days of gestation and are
arranged in a circumferential pattern at the base of the pregnant horn (Steven, 1982). The
annulate portion of the trophoblast and chorionic girdle invaded the endometrium during
formation of the endometrial cups. The cups themselves are made of large decidual-like
cells of fetal origin (Allen, 1975) rather than of maternal origin as previously stated by
Allen and Moor (1972). There is no physical integration between fully formed cups and
fetal membranes (Allen and Stewart, 1978). They contain lipids and other materials to
synthesize and secrete eCG and other substances (Yamauchi, 1975). Cups reach
maximum size of 2 to 10 cm in diameter, and 1 to 3 cm in width by 70 days of gestation
(Allen and Stewart, 1978). According to a study by Douglas and Ginther (1975),
endometrial cups reached maximum weight around 60 days of gestation, and did not
decrease significantly in weight until 180 days of pregnancy. In general, the cups were
desquamated completely by 100 days of pregnancy, and 4 g of necrotic tissue remained
until 140 to 160 days of gestation.
Width and development of the progenitor chorionic girdle appears to be governed
by paternal genotype. For example, a narrower chorionic girdle present in donkey and
mule conceptuses results in formation of smaller endometrial cups. If mule embryos are
transferred to a recipient, this transfer results in the development of a small chorionic
girdle, giving rise to small endometrial cups at 36 to 38 days of gestation (Allen et al.,
1993). It was shown by Meadows et al. (1995) that failure of the donkey-in-horsechorionic girdle to invade in vivo was not attributable to any defect in girdle cells
themselves, but rather to the lack of some intrauterine stimulus.
Similar studies done by Allen and Short (1997) involving transferring donkey
embryos to horse mares resulted in development of a small chorionic girdle that failed to
invade the endometrium to form endometrial cups. Approximately 70% of pregnancies
were aborted between 80 to 85 days in conjunction with delayed and abnormal placental
attachment, along with vigorous maternal cell-mediated reaction against the xenogeneic
donkey trophoblast. Normally, invasive trophoblast cells initiated the attachment and
interdigitation of the non-invasive placenta for fetal sustenance, as well as the modulation
of the materno-fetal immunological interaction to enable survival of the antigenically
foreign fetus in the uterus.
According to Allen (1982), after about day 80 of pregnancy, endometrial cups
become increasingly pale and begin to release a sticky, honey-colored secretion that
adheres to the surface of the overlying allantochorion. This exocrine phase indicates the
beginning of steady degeneration that finally results in necrotic cup tissue due to poor
vascularization (Enders et al., 1995; Lea et al., 1995), and exocrine coagulum being
sloughed from the surface of the endometrium between days 120 to 150 (Allen, 1982).
As endometrial cups mature, lymphocytes increase and accumulate in the
endometrial stroma at the cup periphery. Allen (1980) noted the leukocyte reaction to
endometrial cups was greater in mares bred to jack donkeys as compared to those bred to
studs, and the reaction was also greater in jenny donkeys carrying a stallion conceptus.
On a molecular level of endometrial cups, Lea et al. (1995) discovered that
endometrial tissue from the gravid horn of the uterus had a population of chromotrope 2R
positive cells that contained transforming growth factor-132 (TGF-2) mRNA transcripts
in the periphery of the cups. This factor suppressed potential cytotoxic activities of
activated killer T cells CD8 lymphocytes. After invasion, mature cups down-regulated
expression of the major histocompatibility complex (MHC) class I antigen, so its
expression was turned off by 45 days of gestation. As a result, greater number of cells
positive for mRNA encoding for TGF-2 occurred around 40 days of gestation rather
than at a later stage. This is important for hybridization of maternal leukocytes in the10
region of the developing cups, and maintenance of the cups until their degeneration
around 80 to 100 days of gestation.
Description of Equine Choriomc Gonadotropin and Other Hormones in the Mare
Equine chorionic gonadotropin (eCG), a highly glycosylated heterodimeric
protein, expresses both FSH-like and LH-like biological activities in non-equine species.
The hormone eCG is the primary luteotrophic agent in the first half of equine pregnancy
along with pituitary gonadotrophins LH and FSH, which stimulate secondary follicular
growth necessary for formation of secondary CL (Stewart and Allen, 1979). In mares
treated with eCG that have functional CL, production of androstenedione, estrogens, and
progestins increased, proving eCG is luteotropic (Daels et al., 1998).
The hormones above, like all glycoproteins, possess a similar a-subunit
polypeptide chain, while eCG, LH, and FSH have a different-subutht polypeptide chain
(Combarnous et al., 1991). Equine a-subunit shows about 80% homology with that of
most mammals, differing only in transposition of tyrosine and histidine at positions 87
and 93 respectively (Hoppen, 1994). The a- and 13-subunits of eCG can be detected as
early as 30 days of gestation in equine placental membranes (McDowell et al., 1993).
The hormone eCG first appears in peripheral blood between 37 to 41 days after
ovulation, and its concentration reaches highest levels between 55 to 70 days of gestation.
It decreases and disappears from serum between 100 to 140 days of gestation (Allen et
al., 1993). There are two types of eCG isolated from pregnant mare serum that differ in
amino acid and carbohydrate composition. Low titer eCG (LT) has less carbohydrates
than high titer eCG (HT), which has more phenylalanine and serine. The HT is also more
biologically active than LT and has a longer half-life. The LT resembles eCG isolated
from trophoblastic tissue. There is also a difference between pony and horse mares
regarding eCG synthesis and chemical composition (Stewart and Allen, 1979).
A study by Albrecht et al. (1997) showed that eCG stimulated luteal androgen and
estrogen production, increasing plasma concentration 2 to 3 fold. Secretion of eCG11
increased luteal estrogen synthesis by transcriptional up-regulation of cytochrome
P450 17a-hydroxylase/17,20-lyase expression from the primary CL, suggesting that
availability of aromatizable androgens could be rate-limiting in luteal estrogen synthesis
prior to eCG production.
It was believed eCG bound the same luteal receptor as equine LH, but with a
lower affinity. For example, eCG only has 4% of the binding activity of LH to LH
receptors. Also, eCG does not exhibit a stimulating effect to testosterone production in
rat Leydig cells like LH (Combarnous et al., 1991).
In another study by Albrecht et al. (1997), there was a 24 hour delay in luteal
androgen and estrogen production after eCG administration, indicating that steroidogenic
enzymes must be synthesized first. This finding suggests that eCG influences luteal
steroidogenesis at the transcriptional level.
In a study by Allen et al. (1993), eCG concentration in serum of pregnant mares
and jenny donkeys carrying normal interspecies and hybrid interspecies pregnancies
suggested production of eCG was influenced by parental gene imprinting. Interspecies
pregnancies resulted in different size, secretion activity, and lifespan of endometrial cups.
Main function of endometrial cups is to secrete eCG in high concentrations (Allen et aL,
1973). Production of eCG ceases before the endometrial cups become completely
degenerate; but hormone levels present in the maternal blood persist for some time
(Steven, 1982). Fetal genotype was found to be influential on eCG levels in maternal
blood (Allen et al., 1973). According to Allen (1982), eCG tended to be higher in smaller
pony breeds than in larger and draft breeds. He noted this inverse effect of mare size
could be due to a dilution effect of greater blood volume in larger mares. Allen and
Stewart (1978) noted that if the mare had twins, eCG concentrations would double, while
eCG levels decreased as mare age and parity increased.
Some other significant hormones in mare pregnancy include prolactin (PRL) and
relaxin. Prolactin was found to be luteotropic in several species. In rat luteal cells, PRL
promoted P4 secretion during short incubations in the presence of lipoproteins (Mennon
et al., 1985). Low PRL levels (4.58 to 0.06 nglml) were used to maintain P4 secretion in
humans. In mares that aborted between 28 to 44 days of gestation, there was no
correlation found between plasma PRL and P4. However, in another study, there was a12
positive conelation in pregnant mares between plasma P4 and PRL levels between 14
to 37 days of pregnancy (Schwab et al., 1990).
Relaxin is produced by the placenta and OT stimulates its secretion; there is no
direct evidence that relaxin inhibits uterine activity in the mare. Its main function is to
soften the cervix of the mare pre-partum (Liggins and Thorburn, 1993). Relaxin can be
utilized to diagnose pregnancy since it is high in concentration between 75 to 80 days of
gestation, remaining elevated until its concentration sharply increases at the expulsive
stage of labor (Stabenfeldt and Hughes, 1987).
According to Beckers et al. (1998), the mare has no placental lactogens, which are
significant in ruminants to stimulate mammogenesis, fetal growth, and maternal
metabolism. Instead, the mare has pregnancy-associated glycoproteins (PAG) to aid in
these functions.
Steroidogenesis and Endocrinology in the Pregnant Mare
The feto-placental relationship is one of interdependence (Cottrill et al., 1991).
The resident fetus manipulates maternal biochemistry to suit its own personal living
standards (Allen, 1984). The placenta is essential in hormone production. From earliest
days of pregnancy, trophoblastic cells are veritable producers of a diversity of hormones.
This endocrine function is particularly evident in the human placenta, as well as in the
mare, which produces protein and steroid hormones in large quantities such as estrogens,
P4 and other progestins, eCG, and relaxin (Beaconsfield and Villee, 1979).
Based on studies by Holtan et al. (1979) using OVX mares, the feto-placental unit
is capable of producing enough progestins to support pregnancy due to various metabolic
pathways as early as 50 days of pregnancy. The placenta produces P4 around 85 days of
pregnancy (Knowles et al., 1993); however, it is not detected in plasma after four months
of gestation (Ganjam et al., 1975). In the mare, the major source of P4 changes gradually
from the ovaries to the placenta between days 50 to 70; concentration of plasma P4
reaches maximal levels around day 100 of gestation (Vivrette, 1994) and decreases from
day 150 to 180 (Holtan et aL, 1975).
As reviewed by Thorburn (1993), the placenta, endometrium, and fetal13
adrenals contain side-chain cleavage enzyme (P450 scc) in late pregnancy. It cleaves
the side chain from cholesterol and is the rate-limiting enzyme in synthesizing P5.
Progesterone (P4) and its metabolites are synthesized in the placenta and endometrium as
well, reaching the myometrium by diffusion.
Pashen and Allen (1979b) stated that converting P5 to P4 via 3-HSD was a
crucial step in synthesizing most steroids including progestins. The placenta has 3-HSD
activated from an early stage of pregnancy, and is able to use maternal cholesterol to
synthesize PS and P4, therefore the fetus is not involved in P4 synthesis since the
placenta produces adequate amounts of it starting around 50 days of gestation. However,
blocking 3-HSD activity did not block metabolism of PS to other progestins, thus an
alternate route of metabolism existed. However, Shideler et al. (1982) found no data to
show the placenta produced P4 prior to 50 days of gestation.
The placenta also contains 3-oxidase, 3-hydroxylase, and 3-hydroxysteroid
dehydrogenase (3-HSD), while 5a-reductase and 20a-hydroxylase are present in the
endometrium. The placenta and endometrium have enzymes that are able to convert P5,
which is of fetal origin, to 5a-DHP, and then to 5a-pregnanes, such as 3-5a and-dioI
(Schutzer and Holtan, 1996; Chavatte et al., 1997).
As for estrogen synthesis, Raeside et al. (1973) discovered the placenta could not
produce estrogens from C21 steroids, but was able to aromatize androgens to estrogens
via other methods. It could not convert P5, P4, and 17a-hydroxylated derivatives to
estrogens either. The mare is capable of producing ringfunsaturated estrogens, such as
equilin. Ring tunsaturated estrogens are biosynthesized by the pathway not involving
triterpene (C30) squalene, the sterol cholesterol (Tait et al., 1983). Pashen and Allen
(1979a) found theE17precursor was dehydroepiandrosterone (DHEA) sulfate.
Bhavnani et al. (1969) found DHEA was the precursor for E1, but not for equilin.
Bhavnani et al. (1969; 1975) isolated 313-5a, f3f-dio1, and 3a-diol along with '4C-labeled
E1, E17, equilin, and equilenin, which indicated they shared a similar biosynthetic
pathway up to isopentenylpyrophosphate using the radiolabeled precursor. Bhavnani and
Short (1973) delineated the classical pathway of neutral and phenolic steroid
biosynthesis: acetate to squalene to cholesterol to a pregnene derivative to androgens, and14
finally to estrogens. They notedE1was formed from DHEA sulfate, since7H-DHEA,
14C-androstenedione, 3H-cholesterol, and '4C-acetate were converted to classical
estrogens, and only '4C-acetate was transformed to ringunsaturated estrogens. Ring
unsaturated estrogens formed after bifurcation in the classical pathway of steroid
biosynthesis. This occurred after formation of mevalonic acid, and before formation of
squalene. The precursor was 1 -14C-isopentenylpyrophosphate. Ringunsaturated
estrogens appear in urine around the fourth month of gestation, reach maximal levels
around 8 to 9 months of pregnancy, and are not present following birth; thus, placental or
fetal enzymes are less likely to be involved.
Ainsworth and Ryan (1970) discovered goat placental tissue was able to
synthesize estrogens from androstenedione in vitro, while Ainsworth (1972) found the
presence of steroid sulfate synthesis in the placenta of cattle, guinea pigs, and sheep.
Channing (1969) reported androstenedione and testosterone could be converted toE1and
E17in equine granulosa cell cultures with 15% horse serum, 30% medium '199,' and
55% Hank's solution. The same author also found acetate could be converted to P4 and
E17, and this pathway was similar to the one in luteal tissue.
In another study, it was discovered equine granulosa cell cultures secreted mainly
P4 and 20a-hydroxy-5-pregnen-3-one, even though ovarian cell types differed
quantitatively rather than qualitatively in their pattern of steroid secretion. Granulosa
cells were found to have all enzymes necessary for biosynthesis of P4 and estrogen
(Channing and Grieves, 1969).
The horse conceptus produces a variety of estrogens and androgens that are
involved in embryonic signaling. Estrogens produced increase around 12 to 20 days
post-ovulation. Marsan et al. (1987) discovered two cell types, high and low density
cells, present in the conceptus that have different steroidogenic potentials. For example,
low density cells (LDC) primarily produced P4, and high density cells (HDC) produced
E17J3.
Holtan et al. (1991) have shown major steroids entering the placenta from fetal
circulation are P5 (most abundant steroid at 422 ± 133 ng/ml), P5-, 3-5a, and-
diol. The fetus delivers P5 in large amounts via the umbilical artery to the placenta for15
metabolism. Progestin 5cc-DHP was one of the major steroids in umbilical and uterine
veins, but not in their respective arteries (Hamon et al., 1991). 3- and 2O-
Hydroxylation predominate in the feto-placental unit. The placenta converts P5 to P4,
which is found in high amounts in the umbilical vein, but no P4 is found in the uterine
vein, which contains 5a-reduced metabolites of P4 and P5; therefore, what little amount
of P4 secreted by the uterus is metabolized before returning to the uterus, and 5a-
reductase activity is present in the placenta (Hamon et al., 1991; Holtan et al. 1991). In
cows and ewes, radiolabeled substrate revealed the major site of 5a-reductase was in the
endometrium along with 20a-hydroxylase, thus 2Oc-5a and a-dio1 were found in the
circulation. As a result,a-diol could be a direct metabolite of P5, or it could be
indirectly synthesized from P5 via P4 and 5a-DHP (Hamon et aL, 1991).
Holtan et al. (1991) measured the concentration of 8 progestins in fetal
circulation, and determined the total amount of progestins in fetal arteries or maternal
veins were similar, but higher than those found in fetal veins or maternal arteries. This
difference in the total amount and concentration of progestins indicated metabolism by
the placenta from the fetus to the mare and vice-versa.
Regarding location of progestins in fetal and maternal circulation, P4 was seldom
located in the uterine vein and never in the maternal artery. Progestins 3-5u and3-dio1
were found in fetal vessels, whilea-dio1 was located in maternal vessels, therefore, 3-
and 2O-hydroxylation was occurring in the feto-placental unit, and 20a-hydroxylation
was present on the maternal side. Progestin 20a-5a was found in highest concentration
in the uterine vein at 738 ng/ml, thus it was produced by the endometrium. It was unclear
why reduced pregnanes predominated (Holtan et al., 1991).
The equine fetal liver is involved in converting Cl 9 steroids to substrates that can
be further metabolized into estrogens in the placenta (Pashen and Allen, 1979b). By day
100 of gestation, the fetal liver increases its enzyme activity in the transformation of
DHEA to 7a-hydroxy-DHEA, which is transported to the placenta where it is further
metabolized and aromatized to equilin and equilenin. Phenolic and ringunsaturated
estrogens in pregnant mare plasma and urine increase around 180 to 210 days and 210 to
240 days respectively. Fetal liver also converts PS to P5-and-diol; P4 to 3-5a16
and 3I3-diol; and 3-5a to 5a-DHP, 20x-5a, and 2O[-5a (Schutzer and Holtan, 1996;
Chavatte et al., 1997).
Comparing a few differences between mare and jenny steroidogenesis, Heap et al.
(1991) noted that in the donkey conceptus, aromatase activity was the same in all feto-
placental tissues, except it was lower in the horse conceptus. There was a higher
proportion of labeled precursor incorporated into E173 by extra-embryonic tissues in the
donkey than in the horse.
Estrogens and progestins are excreted significantly in bile and reabsorbed in the
gastrointestinal tract (G1T), especially in humans. Intestinal microflora and mucosa
contribute significantly to levels of active hormones in the organism due to biliary
excretion of these metabolites (Adlercreutz et al., 1979). This may be the case in the
mare (Miller and Holtan, 1997).
Adlercreutz et al. (1979) identified and quantified 12 estrogens in human feces
along with P4 metabolites that were found in unconjugated, monosulfate, disulfate, and
glucuronide form in feces. There were more 3-5a-pregnane isomers and 17a-pregnane
derivatives in pregnant feces than in bile due to 3-hydroxysteroid oxidoreduction and 16-
dehydroxylation of biliary pregnanes by intestinal bacteria, such as Bacteroides fragilis,
which convertedE1to E17. Such studies would be significant to determine if this affects
mare steroidogenesis and steroid excretion.
With regard to other steroid biosynthesis in the mare, active cortisol is converted
to inactive cortisone by 11 -hydroxysteroid dehydrogenase (11 f3-HSD) in the placenta,
which protects the fetus from excess maternal cortisol (Chavatte et al., 1995).
Embryological Development of the Equine Fetus
Survival of the foal at birth begins at conception and depends on normal
intrauterine development, pre-partum maturation of organ systems vital for extra-uterine
life, and an uncomplicated delivery at full term (Rossdale, 1993). Following a few days
after conception, Barer and First (1983) noticed the conceptus spend 144 hours at the
ampullary-isthmic junction of the oviduct before entering the uterus. An important17
function of the conceptus at this point, as noted by Hershman and Douglas (1979), is
the blastocyst must be present in the uterus by day 12 post-ovulation in order to prevent
luteal regression in the mare. Allen (1980) and Enders et al. (1988) found only fertilized
eggs enter the uterus around 5 to 6 days post-ovulation, and unfertilized eggs remain in
the fallopian tubes. Previous reports have suggested that the blastocyst reaches 2 mm in
diameter around 9 days post-ovulation and grows rapidly (3.4 mm/day) to reach 24 mm
by day 16 of gestation (van Niekerk and Allen, 1975; Ginther, 1992). The blastocyst
remains spherical until 50 days of gestation (Bazer and First, 1983). More recent
research by Allen (2000) states that the blastocyst becomes more elongated after 21 days
of pregnancy. The conceptus is mobile in the uterus from the time of entry into the uterus
to 15 days of gestation, traveling to all portions of the uterus 10 to 20 times per day.
Mobility decreases by day 15 of gestation and ceases by day 17 (Gastal et al., 1996).
This process, called the "maternal recognition of pregnancy," prevents luteolysis and
subsequent early embryonic loss.
Fixation generally occurs in the caudal part of the uterine horn near the
bifurcation of the uterine body and horn around day 16 post-ovulation (Enders and Liu,
1991). Gastal et al. (1996) noted that the larger the embryonic vesicle, the sooner
fixation will occur. It was shown that more than 80% of conceptuses implanted in the
horn opposite to the one occupied by a previous pregnancy. Allen (1984), however,
found placentation was random in maiden mares.
In general, an increase in uterine tone during fixation is associated with a decrease
in uterine diameter; therefore, the expanding embryonic vesicle is fixed in the bend in the
caudal portion of the uterine horn. Side of cord attachment is the same as the side of
fixation (Ginther, 1994).
The conceptus is surrounded by an acellular glycoprotein capsule until 22 days of
gestation, relying on endometrial gland secretions for its sustenance (Stewart et al.,
1995). Its heartbeat can also be detected via ultrasound on day 22 of gestation (Squires et
al., 1988). Griffin and Ginther (1991) noted that the early fetus (69 to 81 days) was quite
mobile and changed positions and location in allantoic fluid several times per hour.
Regarding organogenesis pertinent to this project, fetal adenohypophysis (anterior
pituitary, AP) was identified on an ultrastructural level by 100 days of gestation.Neurohypophysis (posterior pituitary, PP) normally develops from the floor of the
diencephalon, and adenohypophysis forms from Rathke's Pouch. The AP is linked
functionally to the thyroid gland, gonads, and adrenal cortex via production of trophic
hormones. In fetal life, these relationships are complicated by feedback of hormones
secreted by the placenta and maternal endocrine organs. For example, in rabbits, little
placental hormones are produced, thus fetal pituitary glands are responsible for
development of the male genital tract, glycogen storage, and adrenal function (Samuel et
al., 1975a).
Placenta and Mechanisms of Placentation in the Mare
From the point of phylogeny, the placenta is a device that evolved when animals
ceased to be oviparous and became viviparous. In placental animals, protection of the
fetus is supplied by the walls of the mother's abdomen and brood pouch, and by amniotic
fluid, which provides flotation in a water jacket and prevents desiccation. The placenta
takes over the nutritive function by establishing a connection with parental circulation,
supplying food substances, and providing developmental building blocks to the fetus
(Ramsey, 1982).
The placenta of the mare is classically described as being non-invasive in its
activity, epitheliochorial in its structure, and diffuse in its architecture (Allen, 1982). In
general, the placenta consists of six tissue layers from the outermost to the innermost
respectively: maternal endothelium, connective tissue, maternal epithelium, trophoblast,
fetal connective tissue, and fetal endothelium (Leiser and Kaufmann, 1994). Collins
(1993) stated that all mammalian placentas develop convolutions at the materno-fetal
interface based on various layers present. For example, pigs have the simplest type of
interdigitation. In the horse, there is no trophoblastic invasiveness, decidual cell reaction,
or formation of the syncytio-trophoblast, which is present in ruminants (Leiser and
Kaufmann, 1994). The large yolk sac is an integral part of the survival of the embryo.
However, early on, the equine embryo develops an unusual glycocalyx capsule that
completely surrounds the embryo prior to the formation of the zona pellucida. This
capsule functions to accumulate proteins and other components of the internal19
endometrial glands or "uterine milk." It becomes dysfunctional around 50 days of
gestation (Jones, 1993).
The three main compartments of the placenta in the mare are the amnion,
allantois, and chorion. The amnion begins to develop around 16 days post-fertilization,
and the amnionic cavity is completely formed by 21 days of gestation (Jones, 1993). The
amnion is an epithelial layer derived from embryonic ectoderm by folding. It achieves
support from the mesenchyme surrounding the fetus (Leiser and Kaufmann, 1994). The
allantois emerges around 25 days of pregnancy, while it begins fusion with the chorion to
develop the allantochorion (Jones, 1993). The pig and domestic ruminant allantois takes
form of an elongated T-shaped sac, which reaches the extremities of the extra embryonic
coelom by passing between the chorion and one side of the amnion. In the mare,
relationships of the allantois are different. Equine allantois grows from the hindgut into
the extra embryonic coelom, and expands dorsally over the amnion. In this manner, the
future umbilicus is subdivided into two distinct yet continuous parts (Steven, 1982). The
allantoic sac stores fetal urine via the urachus (Jones, 1993). The chorion is the epithelial
layer derived from the outer blastocystic wall (Leiser and Kaufmann, 1994). The band
that completely encircles the blastocyst is known as the chorionic girdle. Cells of the
chorionic girdle atrophy and leave a scar. The actual girdle separates from the conceptus
at 40 days of gestation and invades the endometrium. Cells then migrate into the stroma
between the uterine glands to establish endometrial cups (Jones, 1993).
Placentation in equids occurs at a later time compared to that in other large
mammals, in part because of the unique blastocyst capsule that envelops the conceptus
until day 23 of gestation (Stewart et al., 1995). The equine blastocyst retains a roughly
spherical shape until about day 21 of gestation (Allen, 2000). Only after about day 40 of
pregnancy does any intimate and stable contact occur between the allantochorion and the
endometrium (Bjorkman, 1973; Allen, 2000). In early pregnancy, except in regions of
developing endometrial cups, the trophoblast lays in simple apposition to the uterine
epitheium. As allantoic vessels begin to vascularize the chorion, short finger-like
evaginations of the chorion develop along their course, until day 40 of pregnancy when
most of the membrane surface is covered by rudimentary primary viii (Steven, 1982).
During the next 20 days, blunt, finger-like viii of the ailantochorion form a tight-fitting20
interdigitation with the villi of the endometrium (Allen, 2000). Attachment between
the uterine epithelium and a wide band of trophoblast in the equatorial region of the
chorionic sac is established around 46 days of gestation. At this time, the trophoblast
consists of tall columnar epithelium supported by a collagenous basal lamina (Samuel et
al., 1976). By day 56, the allantochorion has expanded from the base of the pregnant
uterine horn into the uterine body, and by day 77, it has extended into the contra lateral
non-pregnant horn. As it continues to do so, a band of modified trophoblast develops in a
relatively avascular region of the chorion just before the leading edge of the allantois
(Steven, 1982).
Between day 60 and 150 of pregnancy, the maternal epithelium is greatly reduced
in height. This modification indicates a change in the requirements of the fetus for
oxygen and metabolites as gestation increases. By day 100 of gestation, primary villi
develop secondary branches (Steven, 1982) marking a complex feto-maternal
interdigitation both at a macro- and microvillous level over the entire endometrial surface
(Allen, 1982). Formation of tertiary villi, a distinctive feature of a mature equine
placenta called microcotyledons, is completed by day 150 of gestation (Samuel et al.,
1974; 1975b), but recent research suggests this process is completed by 120 days of
pregnancy (Allen, 2000). Microcotyledons are believed to represent principal sites of gas
and small molecule exchange (Steven, 1982). Their arrangement is consistent with the
counter-current blood flow system in the mare and other species (Silver, 1984).
There is intense pinocytotic activity by trophoblast cells as well as development
of rough endoplasmic reticulum (RER) and cellular organelles during the first 200 days
of gestation. By 300 days of gestation, smooth ER (SER) is developed. The HSD
enzymes, which play a role in steroid interconversions in trophoblast tissues, are
correlated with the development of SER. These changes suggest trophoblast cells are
more highly involved in synthetic processes as the time of pregnancy progresses (Samuel
etal., 1976; 1977).
On a molecular level of placentation, the mare is an excellent model to study
cellular events associated with early pregnancy because uterine and embryonic tissues
can be collected easily for experimental purposes (Brady et al., 1993). In-situ
hybridization results of Stewart et al. (1995) supported the proposed model of girdle21
development, and provided strong evidence that a component of mesoderm-derived
mitogenic stimulus was hepatocyte growth factor-scatter factor (HCG-SF) and its
receptor, proto-oncogene c-met. The HCG-SF was strongly expressed in allantoic
mesoderm, and c-met was expressed strongly in trophoblast tissues. For example, HCG-
SF induced epithelial differentiation of mesenchyme in chorionic girdle cells during
embryonic development.
According to Lennard et al. (1995), in-situ hybridization techniques and Northern
blotting revealed transforming growth factorIi(TG931), a multifunctional growth factor,
was responsible for regulating endometrial and/or trophoblast growth and differentiation
during placentation. It could also influence fetal development, via placental transfer, at
later stages of gestation.
Northern blot and in-situ hybridization techniques performed by Lennard et al.
(1998) have demonstrated an increase in mRNA encoding epidermal growth factor (EGF)
in endometrial tissues of mares, coincident with interdigitation between the
allantochorion and endometrium during placentation. The EGF was found to play an
important role in placental and fetal growth throughout gestation. High EGF expression
was shown to be in the epithelium of endometrial glands until about day 250 of gestation.
Binding of EGF was high in fetal membranes before implantation (day 30 to 34 of
pregnancy), and in the fully developed placenta (day 150 to 250 of gestation). Since EGF
could be secreted in the uterine lumen, it could stimulate maternal or fetal epithelial
layers of the placenta, and be transferred to the developing fetus. An unusual feature
about EGF was that it was expressed as a large, membrane bound precursor molecule that
underwent proteolytic cleavage at the membrane level to release growth factors.
Upregulation of EGF could be due to increasing levels of eCG, estrogens, and
progestagens.
Schorpp-Kistner (1999) discovered JunB, an immediate early gene product and
member of the AP- 1 transcription factor family, seemed to be essential to the embryo in
establishing proper vascular interactions with maternal circulation. The JunB was
involved in multiple signaling pathways regulating genes that established a proper feto-
maternal circulatory system, since placentation requires extensive angiogenesis to begin
transplacental exchange between the mother and fetus. The trophoblast is rich in22
angiogenic growth factors (VEGF) and proliferin secreted by trophoblastic giant cells
that stimulate uterine neovascularization.
Unlike in the mare, human mechanism of placentation uses VEGF and placental
growth factor (P1GF). Both are used to induce endothelial cell proliferation (Iruela-
Arispe, 1997). McDowell et al. (1995) described another important protein found in the
mare endometrium that plays an important role in placentation. Retinol binding protein
(RBP) is a specific carrier protein for retinol, which is involved in hematopoiesis and
differentiation of the retina during embryogenesis. The RBP is produced by the
conceptus and endometrium, has acid phosphatase activity toward P-nitrophenyl
phosphate; E17f3 and P4 control changes in it. Total protein concentrations increase with
advanced luteal function and decrease with a decrease in P4. RBP was also found in the
endometrium of cows, ewes, and sows, although there were some species differences in
the effect of ovarian steroids on its production.
Badinga et al. (1994) studied uterine expression of mRNA encoding
antileukoproteinase (ALP) and its role in elastase and cathepsin G protease inhibitor in
feto-maternal interactions in pregnant horses, cattle, rats, and mice. They found
abundance of ALP mRNA in the equine endometrium, which increased between 125 to
170 days of gestation, and decreased by 215 days of pregnancy. The ALP expression
established distinct uterine-placental interactions. Increase in ALP levels was due to an
increase inE17concentrations. Both ALP and uterine cathepsin G protease inhibitor
were important in preventing enzymatic degradation of the uterine-placental interface.
With brief regard to placental physiology, the placenta in general behaves like a
lipid membrane towards exogenous compounds such as environmental pollutants, drugs,
and other ingested chemicals. In contrast, all substances essential for fetal development
(apart from respiratory gases) cross the placenta against an electrochemical gradient.
This is a process of considerable specificity. For example, the placenta differentiates
between those proteins being transported to the fetus and those that undergo proteolysis
in placental tissue (Beaconsfield and Villee, 1979).23
Structure and Function of Fetal Gonads in the Horse
Sexual differentiation of the fetus occurs around 39 to 45 days. Gonadogenesis
occurs at the genital ridge with migration of gonocytes from the primitive hindgut. Sex
chromosome complement of gonocytes has no influence on sex determination and
gonadal blastema cells, which manifest their sex chromosome complement during the
development of gonads, although eCG may influence stimulation of gonadal hypertrophy
(Walt et al., 1979).
Early cytodifferentiation of somatic cells into steroidogenic cells takes place
before sex differentiation of gonads. Seminiferous cords of testis are completely
segregated from steroidogenic tissue by a basal lamina, and in the medullary of the ovary,
steroidogenic cells are differentiated inside epithelial cords containing germ cells.
Females remain undifferentiated for a longer time, and no steroidogenic tissue is found
before folliculogenesis takes place. Mesothelium, mesonephros, and mesenchyme
participate in establishing undifferentiated gonads in the horse and rat, but with certain
differences, such as no formation of undifferentiated gonadal blastema in the horse. Fetal
ovaries are enclosed in a cortical layer surrounded by germinal epithelium around 40 to
45 days of gestation. Oocytes are present between 90 to 120 days of gestation deeper
within the cortex of the ovary (Walt et al., 1979).
Allen (1980) noted that fetal gonads enlarge around 100 days of gestation and are
often larger than maternal ovaries between 230 to 250 days; therefore, their growth is
paralleled by a sharp increase in conjugatedE17in mare blood and urine. The reason for
gonadal increase around 250 days of gestation is due to hypertrophy and hypoplasia of
Leydig cells, which are predominant cell types in both sexes; these play a role in steroid
biosynthesis or detoxification of xenobiotic compounds. Hay and Allen (1975) stated
that despite gonadal enlargement, there seems to be no change in the ultrastructure of
gonads between 100 to 250 days of pregnancy. However, Merchant-Larios (1979) found
the absence of ultrastructure differentiation of steroidogenic cells did not indicate
steroidogenesis was not occurring. After 300 days of gestation, gonads regress and
degenerative changes occur in interstitial cells, but no marked ultrastructural differences24
from younger gonads are evident, except that dense bodies are more numerous, larger,
and less regular in shape (Merchant-Larios, 1979).
Gonads contain lots of SER in the third month of gestation, indicating they are
highly developed and function in steroid synthesis, lipid storage, and detoxification
(Gonzalez-Angulo et al., 1975). Hydroxylating activity of cytochrome P450 system is
observed in fetal testes, therefore biosynthesis of steroids is present (Rogerson et al.,
1993). Despite this, Flood and Marrable (1975) found fetal gonads lack HSD enzymes,
but a variety of these are found in trophoblast tissue as early as 13 days post-ovulation.
Fetal adrenal glands and kidneys have limited HSD activity, unlike in sheep which use
3f3-HSD substrates in mid-gestation. The fetal liver in the horse has limited 313-HSD.
However, HSDs are located in the trophoblast, uterine epithelium, and endometrial cups,
therefore lots of steroid conversions are occurring. Although the cups contain HSDs, this
does not mean they have important steroidogenic function; instead, this indicates their
line of descent.
Gonads have a high content of z5-steroids and DHEA (Hay and Allen, 1975)
along with 5,7-dienes, 3-hydroxy-5,7-pregnadien-20-one, and 3J3-hydroxy-5,7-
androstadien-l7-one, indicating the presence of a 5,7-diene pathway to synthesize equilin
in the placenta (Tait et al., 1983). The DHEA is converted to estriol (E3) and other
estrogens by the placenta as well (Hay and Allen, 1975). When gonads regress around
280 days of gestation, there is a decrease in DHEA output, causing a fall in estrogen
levels in mare plasma (Pashen and Allen, 1979b).
In other studies, guinea pig, cattle, and rabbit ovaries were able to convert
testosterone to E17f3 at the same age that testes began to secrete testosterone. There was
no difference found with respect to steroids secreted by the fetal ovaries or fetal testes
(Merchant-Larios, 1979). Complete fetal gonadectomy (GX) results in a rapid decrease
in maternal estrogens, but only to one-half the total amount if only one fetal gonad is
removed (Raeside et al., 1973). In subsequent work, Pashen and Allen (1979a) reported
similar reductions in maternal estrogens following fetal GX, but found that progestins
remained elevated. From this same work, they reported lower 13,14-dihydro-15-oxo-
PGF-2a (PGFM) at term after GX, and thus reduced uterine contractions and difficult25
births in some mares (Pashen and Allen, 1979b). Barnes et al. (1975) indicated fetal
estrogen and progestin levels were much higher than those found in the mare in late
gestation.
Fetal Loss in the Mare
Early pregnancy loss (EDL), defined by Ginther (1985b) as "...degeneration and
resorption of debris and placental fluids and expulsion of the embryonic vesicle through
the cervix," is of major concern to horse breeders. Approximately 12.5% of mares
diagnosed pregnant on equine brood farms are victims of EDL. Ginther (1985a) stated
pregnancy loss occurs between 7 to 17% in individual mares, and abortion is less likely to
occur after 60 to 75 days of pregnancy. However, fetal death is more likely in maiden
mares, geriatric, and/or malnourished mares between 25 to 31 days of gestation (Irwin,
1975; Ginther, 1985a; Woods et al., 1987; Woods, 1989). van Niekerk and van Niekerk
(1998a) stated embryonic loss depended on a variety of factors such as etiology of
disease, endometrial cysts, twin pregnancies, environmental conditions, history,
chromosomal abnormalities, and others. In general, most pregnancy failures resulted
from abnormal fetal development or abnormal uterine environmental conditions, rather
than primarily due to P4 deficiency or CL insufficiency (Forde et al., 1987; Stabenfeldt
and Hughes, 1987). Irvine et al. (1990) supported this finding because pregnancy loss
between 17 to 42 days of gestation was rarely coincident with a fall in plasma P4, since
P4 generally decreased after abortion. Darenius et al. (1991) noted the most critical time
for pregnancy loss was up to 4 to 5 weeks of pregnancy. Good management and minimal
stress were suggested as preventive methods.
During early pregnancy, low or decreasing P4 concentrations were used to
diagnose "at risk" mares. However, Jeffcott et al. (1987) stated measuring maternal P4
concentration is often unreliable to diagnose embryonic death because pseudopregnancy
could occur, thus high P4 levels could be present even during fetal loss. They suggested
monitoring fetal well being viaE1concentrations after 40 days of gestation instead.
Consistent concentrations of >4 ng/ml of P4 were associated with embryo
survival. II P4 concentrations were low on day 4 of gestation, this aided in differentiatingluteal insufficiency from premature, uterine-induced luteolysis until day 5 of
pregnancy when the primary CL was most susceptible to luteolysis (Ginther, 1985a;
Ginther et al., 1985). This could be caused by inadequate stimulation of granulosa cells
at ovulation by LH, resulting in improper CL formation due to being fed low quality
protein lacking essential amino acids necessary for proper LH production (van Niekerk
and van Niekerk, 1998b). However, colic, navicular disease, acute babesiosis, and
treatment with prednisolone and anabolic steroids could cause a dramatic drop in overall
progestins in mares (Ginther, 1 985a; Villahoz et al., 1985).
According to Ginther (1985a), there was a positive relationship between luteal
phase P4 concentrations and pregnancy rate in cattle and sheep. Short interovulatory
intervals due to luteal regression also occurred repeatedly in mares.
Bell and Bristol (1987) found no difference between pregnancy loss occurrence
between mares treated with exogenous progestins andE17as compared to control mares.
With respect to pregnant mares, mean P4 levels were lower on day 14 post-ovulation in
mares that were not pregnant, and in mares that resorbed their pregnancies between day
14 and 21 of gestation.
Bergfelt et al. (1992) found luteal regression resulted in pregnancy loss occurring
before day 20 of gestation. Low P4 concentrations and decreased CL diameters were
present on day 12, 15, and 18 of fetal loss. A decrease in P4 concentration before or on
the day of fetal death has been associated with acute endometritis. Daremus et al. (1987)
noted when early fetal death occurred, the embryonic sac collapsed and its content spread
into the uterus. According to Irvine et al. (1990), a decrease in P4 concentration was
rarely a cause of pregnancy loss.
However, Bergfelt et al. (1992) associated early embryonic loss with a decrease in
P4 due to endometritis, failure of the conceptus to block luteolysis, and primary luteal
insufficiency or regression. Ginther et al. (1985) noted that primary CL insufficiency
was inadequately documented as a cause of fetal loss, and the primary CL was
maintained if embryonic loss was >20 days of gestation rather than earlier. Bergfelt et al.
(1992) found the resurgence of primary CL, along with an increase in size and P4
production, occurred in many mares between 35 to 40 days of gestation due to eCG
release into the circulation.27
Exogenous Hormone Treatment in the Mare
Exogenous hormone treatment is indicated for cases with documented luteal
insufficiency and P4 deficiency, and a history of abortion. Pregnancy loss is
considerably greater during the first trimester, especially between days 0 to 39, and
usually if P4 levels are less than 2.0 ng/ml in the blood (McKinnon et al., 1988a). As a
result, P4 therapy is initiated after breeding and often continued to mid- or late-gestation.
Although treatment is expensive at $4 per mare per day, and since current diagnostic tests
(radioimmunoassays (RIAs)) are inconclusive, owners often choose treatment. However,
using RIAs could indicate problem mares that have low or decreasing total progestins
preceding infectious or non-infectious abortions. If treatment is initiated and no clear
rationale of treatment termination is available, current recommendations state stopping
treatment at 80, 100, or 150 days, or simply continuing treatment until term (Rossdale et
al., 1991). Current treatment of choice is the synthetic progestin Regu-Mate® (17x-
Allyl- 17-hythoxyestra-4,9, 11 -trien-3-one; altrenogest; Hoeschst-Roussel, Agri-Vet Co.;
Sommerville, NJ 08876). Contraindication to P4 therapy includes bacterial uterine
infection, since the uterus has limited ability to clear infections under P4 influence
(Wilker et al., 1992).
In order to determine the effectiveness ofReguMate®on early pregnancy
maintenance, Voller et al. (1991) worked with nine pregnant pony mares. Regu-Mate®
was administered orally at 0.044 mgfkg to each mare daily starting day 4 post-ovulation.
An injection of PGF2 (3 mg, IM) was given on day 10 post-ovulation to each mare to
regress the primary CL. This resulted in decreased P4 levels (<1 ng/ml), which remained
at this level until secondary CL formed. Only 4 out of 9 mares maintained pregnancy
regardless of treatment. Their secondary CL formed between days 32 and 85 of
pregnancy, along with increasing P4 levels; the other 5 mares had resorbed fetuses
despite Regu-Mate® treatment. WhenPGF2awas administered to each mare at days 65
and 75 of gestation, abortion did not result and accessory CL did not regress completely
(Voller et al., 1991).ReguMate® also didnot affect accessory ovulation or accessoryluteal function when compared to non-treated pregnant controls (Parry-Weeks and
Holtan, 1987). However, repeated injections of PGF2a(5 mg, IM, BID) resulted in
abortion despite Regu-Mate® treatment. Schideler et al. (1982) also discovered 1 ml
Regu-Mate®/50 kg was not sufficient to maintainpregnancy in OVX mares beyond about
day 40 of gestation.
Contrary to previous studies, no new secondary CL were formed with Regu-
Mate® treatment, indicating this particular treatmentwas inhibitory until day 70 of
gestation (Daels et al., 1991a).
In a study by Naden et al. (1990), Regu-Mate® administration to pregnant mares
resulted in enlarged citori that had no effect on the functional reproductive performance
in fillies born to treated mares. Thus, ReguMate® treatment was deemed safe to use in
pregnant mares. Similarly, Ballet al. (1992) found administration of 450 mg of Regu-
Mate® to pony mares daily between 0 to 6 days after ovulation did not significantly affect
early embryonic development, as compared to control mares.
In another study, Regu-Mate® given the last 20 to 30 days of gestation did not
increase the length of gestation. In the same study, ReguMate® increased mammary
development due to an increase in exogenous progestin levels (Chavatte et al., 1997).
Daels et al. (1991b) induced fetal loss via endotoxemia during 21 to 35 days of
gestation. Mares were treated with ReguMate® daily to compensate for the loss of
endogenous P4 secretion. Plasma P4 decreased 24 hours post-injection with an
endotoxin, but daily treatment with ReguMate® prevented embryo loss in mares <2
months pregnant. If Regu-Mate® was discontinued at 40 days of gestation and P4
concentration was <1 ng/mll, fetal death would result 4 days later. Continuation of
treatment was recommended until 70 days of pregnancy. If mares were OVX at day 30
of gestation, pregnancy was maintained with 22 to 44 mg/day of Regu-Mate® given up to
100 days of pregnancy.
A study by Jackson et al. (1986) stated exogenous progestins would alter
serum concentrations of P4 in the mare. The study indicated Regu-Mate® did not alter
endogenous P4 levels if 22 mg were administered daily (P0).29
Knowles et al. (1993) performed a study with pregnant OVX mares,
administering 100 mg Regu-.Mate® daily for the first 30 days of gestation. Endogenous
P4 levels were measured at 91 days of gestation in pregnant OVX mares. Progesterone
(P4) concentration was >1 ng/ml in blood, indicating placental P4 secretion at that time,
as compared to intact mares whose increase in P4 concentration between 60 to 100 days
was of ovarian origin.
Ganjam and Kenney (1975) performed a study on OVX mares and gave them 150
mg (IM, once daily) of exogenous P4. They measured P4 plasma levels and found it took
21 days to increase P4 levels in plasma to 6 to 7 ng/ml, and when the dose was doubled,
it took 14 days to increase it to that level if they were treated daily. Since it is common
practice to put a mare on Regu-Mate® at 200 to 250 mg every 10 to 30 days to prevent
abortion, the study showed this was an inadequate measure, since it took 14 days at 300
mg administered daily to obtain desired plasma P4 levels. It was recommended
administering 500 mg every other day starting at day 40 of gestation, and continuing this
until a week prior to parturition.
Other uses for ReguMate® were to allow the extension of the donor-recipient
ovulation synchrony required for successful non-surgical embryo transfer in mares
(Parry-Weeks and Holtan, 1987), to control estrous cycling in mares during the late
transitional phase, and to do the same in normally cycling mares (Squires et al., 1983).
The latter is an effective method to reduce erratic sexual behavior typical of the transition
period. Only mares with considerable follicular activity (several 20 to 30 mm follicles)
should be selected for exogenous progestin treatment (Squires et al., 1984).
Other preparations administered to problem mares include melengestrol acetate,
proligestone, chlormadinone acetate, hydroxy-progesterone caproate, and
medroxyprogesterone acetate, which are all synthetic progestins. There are anecdotal
reports of their use for pregnancy maintenance, but experimental evidence of
effectiveness is poor or lacking (Wilker et al., 1992). For example, hydroxyprogesterone
caproate is widely used in Australia to prevent early pregnancy loss, but is ineffective due
to a lack of binding affinity for equine P4 receptors in the endometrium (Allen, 1993).
Instead, ReguMate® is the treatment of choice in most instances. Despite Regu-Mate' s®30
popularity and effectiveness, Allen (1982) found it tended to hasten the demise of
existing CL, and did not increase fetal survival rates.
Ovariectomy (OVX) and Hysterectomy (HX) in the Mare
Holtan et al. (1979) noted humans, horses, and sheep OVX at 50 days of gestation
did not abort, since the placenta produced adequate P4 to maintain pregnancy. This could
be due to the fact that the myometrium continues to be bathed locally by P4 and its
metabolites, because the placenta synthesizes these at that time. They also found if some
mares were OVX before 50 to 70 days of gestation, they would abort. However, if OVX
between 140 to 210 days of gestation, fetuses were carried to term, implicating ovaries
were not needed at this stage to maintain pregnancy.
Endogenous P4 in OVX pregnant mares was >1 ng/ml by 91 days of gestation,
indicating placental secretion of P4. Serum concentrations of progestins in ovary-intact
pregnant mares were greater than those in OVX mares until 130 days of gestation, and
from then on they were the same. In conclusion, ovaries were a significant source of
progestins until 130 days of gestation, and the feto-placental unit was the source of
progestin production from 100 days of gestation (Knowles et al., 1994).
Regarding estrogen levels in OVX mares, Daels et al. (1990) found mean
conjugated estrogen (CE) concentrations increased in a constant linear manner from 17
ng/mg creatinine (Cr) on day 20 of gestation to 291 ng/mg Cr on day 70 of pregnancy, as
compared to intact mares, which had a mean concentration of 201 to 172 ng/mg Cr
between 20 to 33 days of gestation respectively, and reached maximal levels at 1066
ng/mg Cr on day 39 of pregnancy. There was a decrease from that point to 637 ng/mg Cr
at 44 days of gestation. There was a linear increase to 1191 ng/ml on day 70 of gestation.
These changes were due to the rate of ovarian synthesis of estrogens.
In a study by Squires et al. (1974), P4 concentration was measured in plasma
in 17 pregnant, 6 non-pregnant (used as controls), and 12 HX mares from 7 to 19
days of gestation and following HX, and 32 to 140 days of pregnancy and following HX.
No difference was found between pregnant and HX mares on days 7 to 19 of pregnancy
or following HX. In mares that were HX at >19 days, there was a linear decrease in P431
levels. Progesterone (P4) concentrations increased between 32 to 44 days in pregnant
mares and continued to increase from >44 days to 90 days of gestation, then decreased
from 150 to 180 days of pregnancy. However, there were differences between mares and
P4 concentrations. Ovulation was detected in 2 out of 12 HX mares 140 days following
HX. It occurred after the primary CL regressed based on a decrease in P4 to 1.6 ng/ml
before ovulation, and with an increase to 8 ng/ml post-ovulation. This study also noted
CL regression occurred earlier in HX mares than in pregnant mares. Secondary CL failed
to form from anovulatory follicles in FIX mares. The conclusion in this study was that
eCG contributed to the maintenance, increased steroidogenesis, and formation of
secondary CL, but was not essential for the growth of follicles during early pregnancy in
mares.
FIX mares had an interrupted pattern of plasma progestin production due to
prolonged CL tissue lifespan. In non-pregnant mares, HX prolonged the lifespan of CL,
since there was no uterus to produce PGF2a. The uterus is important for the initiation of
regression of CL in normal, non-pregnant mares, but all HX mares had follicular activity
despite high levels of circulating progestins (Stabenfeldt et al., 1974).32
CHAPTER 3: EXPERIMENTAL DESIGN
Objectives
Previous studies by Riad and Holtan (1993) have shown urinary hormones PdG
and E1S in mares increased abruptly around85to 90 days of gestation. It could be
concluded the feto-placental unit was functional at that time; therefore one objective of
this study was to describe an accurate profile of total and individual progestins found in
plasma and fecal samples taken every other day from 64 to150days of gestation.
Another goal was to correlate individual plasma to fecal progestins over time. The final
objective was to determine an accurate time frame, using spline regression, of abrupt
changes in plasma and fecal progestins, similar to findings for the urinary hormones.
This data may help define when the feto-placental unit is adequately functional to
maintain pregnancy.
Materials
Animals (n = 4 pregnant mares) were housed at the Oregon State University (OSU)
Horse Center. Mares were two Shetland ponies and two Quarter Horses of various ages
with no known reproductive pathology. Pony mares were bred artificially (A.I.) to the
same Shetland stallion, and horse mares were bred A.I. to the same Quarter Horse stallion
between June and July 1999, with the day of breeding being day 0 of pregnancy. Three
mares were kept on grass pasture, while the fourth mare was kept in an outside run due to
a foot injury. All subjects had water and trace minerals available at all times.
Sample Collection
Plasma and feces were collected from pregnant mares (n = 4) every other day
from day 64 to 150 of gestation. Blood was collected by jugular venipuncture into33
heparinized tubes (Vacutainers, ® Beckton & Dickinson; Rutherford, New Jersey
07070). Plasma was separated after centrifugation and stored at -18°C. Fecal samples
were stored at -18°C.
Ultrasound Procedures
Ultrasound procedures were conducted as instructed by Ginther and Pierson
(1984a, 1984b), McKinnon et al. (1988b), and Squires et al. (1988). An ultrasound
machine, model ALOCA 210 DX, was used along with a 5 MHz probe (Corometrics
Medical Systems Inc.; Wallingford, CT). Follicles, CL, and CH were counted and their
diameters were measured with built-in calipers.
Sample Preparation
Deuterium (D4) labeled progestins (500 ng each) of D4-5a-DHP, D4-P5,
D4-3-5a, D4-5-DHP, and D4--diol were added as the internal standards (ISTD).
Deuterium labeled progestins were prepared as described by Dehennin et al. (1980).
Extraction methods followed established methods by Holtan et al. (1991) and Schutzer
(1995).
Standard curves were generated with ChemStation software (HP, version
G1034B) by adding 500 ng of each D4 standard to each of the five vials containing a
range from 125 to 2000 ng of non-labeled standard in ovariectomized (OVX) mare
plasma or gelding feces. Non-labeled standards were 5a-DHP, 513-DHP, P4, 3a-5a, 33-
5a, 2Oct-5x, P5-13f, 20f3-5a, c4E-diol, aa-diol,-diol, and 3a-diol. For each, a standard
curve of the response ratios was developed using the D4 standard most similar in
structure. The assumption is that similar hormones under the same extraction and
derivatization procedures will be recovered in similar proportions. Quantitation consisted
of calculating least squares linear regression of standards versus their D4-ISTD. Thus,
least squares linear regression for each steroid within each assay would be calculated
from the peak area ratios (unlabeled standards versus D4-ISTD).34
Samples of 5.0 ml of plasma or 0.5 g of feces were diluted with deionized
water (1:l,v:v). Samples were then passed throughC18Sep-Pak® cartridges (PrepSep-
C18; Fisher Scientific; Fair Lawn, NJ 07410) usinga vacuum system (Waters Company;
Milford, MA). Prior to sample washing,C'8Sep-Pak® carthdgeswere charged with
methanol (MeOH) (HPLC grade; 2 ml) and rinsed with deionized water (2 ml). After the
entire sample passed through the cartridges, it was rinsed again with deionized water (5
ml), followed by hexane (HPLC grade; 1 ml). Unconjugated steroids were extracted
from the cartridge bed with anhydrous diethyl ether (4 ml) into 4-dram vials. The ether
was evaporated under a stream of air at 60°C.
Ketones were derivatized to methoximes with 50 p.1 of 5% methoxyamine-HC1
(MOX; Sigma Chemical Company; St. Louis, MO) in silation grade pyridine (Regis
Technologies Inc.; Morton Grove, IL) at 60°C for 30 mm. in 4-dram vials with Teflon
coated caps. Pyridine was subsequently evaporated under a stream of air at 80°C.
Samples were then incubated for 45 mm. at 80°C with 25 p.1 of N-methyl-N-(t-
butyldimethylsilyl) trifluoroacetamide (MtBSTFA; Regis) and 50 p.1 of 5% diethylamine
(DEA; Sigma) in silation grade dimethylformamide (DMF; Regis) as the catalyst.
Derivatization of unhindered-hydroxyl groups to tert-butyldimethylsilyl (tBDMS)
occurred at this step, and was stopped by adding 0.5 ml of deionized water to each
sample.
Derivatives were extracted from the aqueous phase with anhydrous diethyl ether
(3 ml; 2X), and then concentrated under a stream of air. Samples were taken up with n-
undecane (Sigma; 30 p.1) and analyzed with GCIMS.
Sample Analysis
Laboratory facilities and equipment for assays, including a Hewlett Packard gas
chromatograph (HP 5890) with autosampler (HP 7673) system interfaced with a mass
spectrometer (HP 5971A) and 486/66 series microcomputer (Hewlett Packard;
Wilmington, DE; ChemStation Software, HP, version G1034B), were available in
Withycombe Hall 317 laboratory.35
Each (1tl) sample was injected (splitless mode) into the GC, which contained
a DB-5MS 30 mX 0.25 mm id fused silica capillary column (J & W Scientific; Folsom,
CA). Samples were then separated under the temperature program mode. Injection port
temperature was isothermal at 250°C, while initial temperature of the GC oven was at
160°C. Upon injection, the GC oven temperature increased 25°C/mm. to 280°C, then
3°C/mm. to 3 10°C. The GC oven remained at 3 10°C for 10 mm.; total run time was 27.5
mm. The MS was operated in full scan mode for initial identification and selected ion
mode (SIM) for routine quantitation.
Statistical Analysis
Eight different progestins were routinely identified and quantified in plasma and
ten in feces. They were 5x-DHP, P4, 3a-5a, 3f-5a, 20u-5a, 203-5a, aa-diol, a-diol,
fa-diol, and 4-diol in feces, while c43-diol and 20-5u were left out in plasma due to
low sensitivity detection. Statistical analysis consisted of using analysis of variance
(ANOVA) with repeated measures split-plot design (SAS, version 8.10; SAS Institute
Inc.; Cary, NC). Since variances were not homogeneous, least squares means (LSM)
were log-transformed. Main effects were mare, sample (plasma or fecal), and day (time
in gestation), and the interactions were sample by day and mare by sample.
Pearson correlation method (SAS) was run on all progestins, except for 20-5a
and c4-diol, to determine if there was a correlation between individual plasma and fecal
progestins over time. A Pearson partial correlation method (SAS) was done on all
progestins, except for 203-5x and a3-diol, to determine if there was a correlation
between individual plasma and fecal progestins without the time effect.
To further study interactions between sample and day, a spline regression (Gauss-
Newton, SAS) method was used to determine a point of rapid increase of slopes in
plasma and fecal progestins. Ratios of feces to plasma were also plotted to demonstrate
interactions obtained from SAS results. This would indicate whether or not plasma or
feces would increase at a different rate over time.CHAPTER 4: RESULTS
Group Mean Results
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The data examines progestins from 64 to 150 days of gestation in the mare. The
data compared a variety of progestins and their concentrations present in plasma and
feces in both pony and light horse mares. Sensitivity of the method used was about 0.5
ng/ml in plasma or 0.5 ng/g in feces. Mean coefficient of variation (CV) among assays
was 27.1%, and within assays, CV was 12.4% as reported by Miller et al. (2000). Least
squares means (LSM) ± standard error (SE) were used throughout (ANOVA general
linear model for repeated measures, SAS) unless noted otherwise. Eight different
progestins in plasma (5a-DHP, P4, 3a-5cz, 3f3-5a, 20a-5u, aa-diol, 33-diol, and a-
diol) and ten in feces (5a-DHP, P4, 3a-5a, 3-5x, 20-5a, 20a-5u, (x-diol, oca-diol,
3-diol, and 13a-diol) were analyzed. Other progestins found, such as P5, P5-, and51-
DHP, were not included in the analysis because they were only sporadically detected.
Plasma 20-5a and c43-diol were often below normal detection, thus they were
disregarded in the analysis.
No statistical analysis or conclusive evidence correlating progestin levels and CL
formation were performed, because it was difficult to identify new CL formation from the
old CL formed. The ultrasound data collected was not reliable due to lack of
repeatability of results and operator inexperience.
Table 1 shows the overall mean progestin concentrations from 64 to 150 days of
gestation in mares (n = 4). Concentrations in feces were approximately 100 times higher
than in plasma for total progestins, yet differed among individual progestins (Table 1 and
Figure 1). Progesterone (P4) concentration remained similar in both plasma and feces
over time. Progestin 20a-5c and 5a-DHP concentrations were about 6 times higher in
feces than in plasma. Progestin aa-diol and 33-5a concentrations were approximately
50 to 60 times higher in feces than in plasma. Progestin 3a-5a concentration was about
150 times higher in feces than in plasma. Progestin 33-diol concentration was37
approximately 800 times higher in feces than in plasma, while kx-diol concentration
was 100 times higher in feces than in plasma (Table 1).
Four progestins were chosen to depict different pauerns over time; these included
3(-5a, 2Oct-5a, 34-diol, anda-diol. Progestin 20x-5cx remained in highest
concentration in plasma over time, while 13-diol was highest in feces (Table 1).
Because of heterogeneity of variance, and the great difference between plasma
and feces, data were log-transformed to eliminate skewness. Figure 1 shows plasma and
fecal LSM increase over time at a steady, linear rate. The slopes of the lines are the same
for total progestins.
Table 1: Mean concentration of progestins in plasma (ng/ml) and feces (ng/g) of mares
(n4) sampled from 64 to 150 days of gestation.
ProgestinaPlasma LSMb ±SEC Fecal LSM±SE
5a-DHP 13.2 0.4 78.9 3.2
P4 5.1 0.3 8.1 0.4
3a-5a 4.0 0.1 584.3 19.3
33-5a 9.8 0.2 582.1 29.1
20a-5ct 26.2 0.4 144.1 8.1
aa-diol 13.1 0.5 602.3 34.4
-diol 6.3 0.2 5159.4 153.2
13a-diol 16.6 0.3 1635.9 68.9
20-5a NAd NA 217.0 12.8
a-dio1 NA NA 490.4 18.5
Total 95.0 1.6 9501.4 242.1
aSee List of Abbreviations for full systematic names
bLeast squares means
CPooled standard error of means
dNot analyzed
Table 2 depicts the analysis of variance for repeated measures for total progestins.
Mare effect was significant indicating a difference between individual animals. Sample
(plasma versus feces) effect was significant showing there was a difference betweenplasma and fecal concentrations. Day was significant demonstrating a general increase
over time, as observed in Figure 1.
Table 3 is a summary of individual progestin analyses performed in a similar
manner as in Table 2. Note that day effect was not significant for P4 because there was a
constant rate of change over time, unlike the other progestins. Sample effect was also not
significant for P4 since there was no difference between plasma and fecal concentrations.
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Figure 1: Mean concentration and pooled standard error (SE) of total progestins
(log) in plasma (bottom line, SE = 0.057) and feces (top line, SE = 0.069) from 64 to 150
days of gestation in mares (n = 4).39
Table 2: ANOVA table for the log concentration of total progestins in plasma and
feces from 64 to 150 days of gestation in mares (n = 4).
Source DFType ifi SS MS F ValuePr>F
Mare 3 7.631 2.544 158.150 Sa
Sampleb 1 302.462302.46213213.800 5
Mare x 3 0.069 0.023 1.420NS
Sample
Day 37 28.448 0.769 47.800 S
Sample x 37 0.3 19 0.009 0.540NS
Day
Error 222 3.571 0.016
Total 303 342.499
aSignificant (P0.05) or not (NS)
bMare x Sample used as error term
Table 3: Summary table of individual plasma and fecal progestins as compared to total
progestins using ANOVA analyses.
Source Total 5a-P43cx-5a3-5a2Oct-5aaa- 4-a-
ProgestinsDHP dioldioldiol
Mare sa s s s S S S S S
Sample S SNS S S S S S S
Marex NS S S S S S S S S
Sample
Day S SNS S S S S S S
Sample NS NS S S S S NSNSNS
x Day
aSignificant(P0.05) ornot (NS)
There were positive correlations in the full Pearson analysis (r = >0.8290, P<0.01)
for all progestins analyzed, except for P4, which was negatively correlated (r = -0.6993,
P<0.01) as shown by Figure 2. There were positive correlations in the partial Pearson
analysis (r = <0.3745) for all progestins analyzed, except for P4, which was negatively
correlated (r = -0.1041), but these low correlations were not significant (P>0.05).1.4
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Figure 2: Mean log concentration and pooled standard error (SE) in plasma
(decreasing, SE0.103) and fecal (increasing, SE = 0.113) progesterone (P4) from 64 to
150 days of gestation in mares (n = 4).
Spline regression was used to determine the point of change between slopes in
plasma and fecal progestins, and to portray an interaction between plasma or feces and
time. Results of the four major progestins, 3-5a, 20a-5a,3-dio1, and a-diol
indicated a change at 112.7 days in plasma (Figure 3) and at 109 days in feces (Figure 4).
There was considerable variation between individual progestins and between plasma
versus feces regarding when the increase in concentration occurred. Spline regression
indicated both mean plasma and fecal 3-5a increased at 110 days of gestation (Figures 3
and 4 respectively). Visually, mean plasma 3-5a appeared to increase dramatically
around 110 days of pregnancy, while its fecal counterpart increased around 90 days of
gestation. Mean log-transformed plasma 3f-5cx appeared to increase visually around 104
days of gestation, and fecal values seemed to rise around 94 days of pregnancy.80
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Figure 3: Mean concentration and pooled standard errors (SE) of plasma
3-hythoxy-5a-pregnan-20-one (3 j3-5cz, SE = 179.753), 20a-hydroxy-5a-pregnan-3-one
(20a-5a, SE = 49.9 19), 5a-pregnane-33,203-diol (343-dio1, SE944.158), and
5x-pregnane-3j3,20a-diol (13a-diol, SE = 424.952) from 64 to 150 days of gestation in
mares (n = 4). Spline regression (SR) indicates mean day (112.7) of increase for all
progestins listed.
Spline regression indicated plasma 20a-5a increased at 114 days of gestation, and
fecal increased at 108 days of pregnancy (Figures 3 and 4 respectively). Visually, mean
plasma 20a-5a seemed to increase rapidly around 85 days of gestation, while its fecal
counterpart increased around 94 days of pregnancy. Mean log-transformed plasma 20a-
5a appeared to increase visually around 85 days of gestation, and fecal values seemed to
rise around 87 days of pregnancy.12O
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Figure 4: Mean concentration and pooled standard errors (SE) of fecal
3-hydroxy-5a-pregnan-20-one (313-5a, SE = 1.405), 20a-hydroxy-5a-pregnan-3-one
(2Ocx-5a, SE = 2.655), 5a-pregnane-33,20J3-diol (3f3-diol, SE = 1.463), and
5a-pregnane-33,20cx-diol (13u-diol, SE = 2.124) from 64 to 150 days of gestation in
mares (n = 4). Spline regression (SR) indicates mean day (109) of increase for 3-5u and
20x-5a only;-diol and a-diol did not show a defined change.
Spline regression indicated the point of change in plasma 43-dio1 increased at
114.7 days of pregnancy, while a decided change in fecal I-diol could not be detected
(Figures 3 and 4 respectively). Visually, mean plasma 43-dio1 appeared to increase
dramatically around 110 days of gestation, while its fecal counterpart increased around
104 days of pregnancy. Mean log-transformed plasmaf3-diol increased visually around
75 and 115 days of gestation, and fecal values seemed to rise around 87 days of
pregnancy.43
Spline regression showed an increase in plasma a-diol around 112.2 days of
pregnancy, but could not detect the change point in fecal ikt-diol (Figures 3 and 4
respectively). Visually, mean plasma 13a-diol appeared to increase rapidly around 75
days of gestation, while its fecal counterpart increased around 85 days of pregnancy.
Mean log-transformed plasma fa-diol increased visually around 75 days of gestation,
and fecal values rose at 87 days of pregnancy.
Visually, mean plasma and fecal aa-diol appeared to increase around 90 days of
pregnancy. Mean plasma and fecal 3a-5a increased around 85 days of gestation. Mean
fecalc4-diolincreased around 85 days of pregnancy. Mean fecal 203-5a increased
around 82 days of gestation. No noticeable change was seen in plasma 5a-DHP, while
its log-transformed value seemed to increase around 100 days of gestation. Mean fecal
5a-DHP increased around 96 days of gestation, while its log counterpart increased
around 115 days of pregnancy.
Ratios of feces to plasma in 3-5a, 20a-5a, and 3a-dio1 were used to visually
demonstrate the interactions between sample and day (Figure 5). There was a positive
slope indicating an interaction between sample and day for 3-5a (Figure 5A); P4 and
3a-5a were similar. This showed a greater increase in feces over time than in plasma. A
negative slope was observed for 20u-5a (Figure SB); aa-diol was similar. A negative
slope indicated plasma was increasing at a faster rate than in feces. Progestin f3a-diol
demonstrated a straight line when there was no interaction between sample and day
(Figure SC), meaning plasma and feces increased at the same rate over time; 5a-DHP and
-diol were similar.
Individual Mare Results
Most differences among mares were seen in 3f-Sa, 20a-5a,-dio1, and a-diol
regarding a notable increase over time. As depicted by Figure 6, there was significant
variation among different progestins, mares, and plasma versus feces regarding the pointI
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Figure 5: Mean ratio of feces to plasma (log) in 3-hydroxy-5a-pregnan-2O-one
(A, 313-5a), 20a-hydroxy-5cx-pregnan-3-one (B, 20u-5a), and 5a-pregnane-33,2Oa-dio1
(C, f3a-diol) from 64 to 150 days of gestation in mares (n = 4).30
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Figure 6: Plasma (A) and fecal (B) 33-hydroxy-5a-pregnan-2O-one (33-5a) in
individual mares from 64 to 150 days of gestation.
70 80 90 100 110 120 130 140 150of increase, which was difficult to determine at times. Table 4 depicts the ranges of
change points in time for spline regression for the four progestins, indicating the
tremendous variability among individual mares. Similarly, log ratios showed this
variability among individual mares, and did not increase the reliability in determining the
change points for spline regression.
Table 4: Spline regression ranges for plasma and fecal 3-hydroxy-5a-pregnan-2O-one
(3f3-5a), 20a-hydroxy-5a-pregnan-3-one (20a-5a), 5a-pregnane-3f3,2O3-diol
(-diol), and 5u-pregnane-3f3,2Occ-diol (f3a-diol) in individual mares (n =4)
from 64 to 150 days of gestation.
Progestin Plasma (days) Fecal (days)
3-5a 80-115 110-117
20a-5cx 109.1-119 108-109.2
3-dioI 78.45-129.4 None
u-diol 95.49-118.4 None47
CHAPTER 5: DISCUSSION
Overview
Aims of this research were to analyze samples taken during 64 to 150 days of
gestation to establish data and comparisons between and among plasma and fecal
progestins; to determine a time frame, using spline regression, when an increase would
likely reflect a functional feto-placental unit; and to compare these findings to the trend
seen with urinary hormones. The method (GC/MS) accurately separated progestins with
similar structures and molecular make-up.
Progestin production in the mare is critical for the maintenance of pregnancy as well as in
other species (Brown et aL, 1994; Miller and Holtan, 1997). Progesterone (P4) plays an
essential role in placentation, embryo development, and placental functions. Profiling
progestins, such as P4, in mid-gestation could be indicative of fetal well being and a
successful pregnancy to term. Determining the time certain progestins increase rapidly
may reflect placental progestin production. Finally, this study may provide some insight
on the necessity of treating problem mares with Regu-Mate® until term, particularly
regarding stopping treatment at a determined time.
Hormone Identification and Quantitation
Holtan et al. (1991) found sensitivity, range, accuracy, and precision of GC/MS to
be at least equal to most immunoassays, including the added benefit of specificity. The
GC/MS allowed progestins to be accurately separated without cross-reactivity, such as P4
in both plasma and feces, than with RIAs. The GC/MS identified 13 total progestins, 8 of
these in plasma and 10 in feces. All plasma progestins identified in this study had been
previously identified by Holtan et al. (1991) using similar GCIMS techniques. Even with
rigorous preparation, purification, and sensitivity of 0.5 ng/ml for plasma or 0.5 ng/g for
feces before analysis, concentrations of P5, P5-1, and 5-DHP in both plasma and feces,
and 203-5a and a-diol in plasma were often low or undetectable at times.In the mare, the major source of P4 changes gradually from the ovaries to the
placenta between days 50 to 70, reaches maximal levels around day 100 of gestation
(Vivrette, 1994), and decreases from day 150 to 180 (Holtan et al., 1975). However, no
data has shown the placenta to produce P4 prior to 50 days of gestation (Shideler et al.,
1982). We detected P4 in both plasma and feces as early as 64 days of gestation, which
could be of placental and/or ovarian origin, but at this point in research, it is difficult to
distinguish the source, even though Holtan et al. (1991) found the presence of reduced
pregnanes in plasma after 50 days of gestation to perhaps indicate placental production.
Furthermore, Burns and Fleeger (1975) stated the increase in progestin
concentration between 30 to 60 days of pregnancy was of ovarian origin. On the other
hand, Vivrette (1994) noted an increase in reduced pregnanes in plasma, such as 20u-5a
anda-diol, between days 30 to 60 of gestation was due to production by the feto-
placental unit. These two progestins were found in high concentrations in plasma and
feces respectively in our study as well. Perhaps these two could be used as indicators to
detect successful development of the placenta in early gestation.
According to a study by Holtan et al. (1991), the predominant progestins in mare
plasma were 20a-5u andu-diol; concentrations were around 25 ng/ml at 100 days of
gestation in both, and at approximately 75 ng/ml and 50 ng/ml at 150 days of pregnancy
respectively. Our findings showed mean 20a-5a andcx-diol were also found in highest
concentration in plasma, but at half the concentration at 100 days of gestation and at
similar levels at 150 days of pregnancy. Our results were also consistent with Burns and
Fleeger (1975) who found 5a-DHP increased around 50 to 70 days of gestation, while P4
decreased at that time. Progesterone (P4) decreased in plasma around 64 days of
gestation and increased in feces (Figure 2), indicating luteal regression and feto-placental
production respectively as reported by Short (1959) and Holtan et al. (1975).
Holtan et al. (1991) found plasma 3ct-5ct increased at the same rate as 3-5a in
late pregnancy, as was the case from 64 to 150 days of gestation in our study. Plasma 3-
5a was almost twice as high in concentration as 3a-5a between 64 to 150 days of
gestation, yet they remained parallel to each other. The same can be stated about aa-diol
andf-dioI, which were almost equal in concentration in late pregnancy (Holtan et al.,49
1991), but aa-diol was almost twice the concentration as-diol from 64 to 150 days
of gestation. The data is supported by previous work done in this lab (Baumholtz, 1998).
Group Mean Results
ANOVA results in Table 2 for the log of total progestins showed all main effects
were significant. Variation among individual mares, plasma versus feces, and time was
expected, since this has been reported by Hamon et al. (1991). Despite mare effect being
significant, this was not a major factor in our study, because it is already expected that
there will be variation among individual mares (Hamon et al., 1991; Baumholtz, 1998).
Averaging tended to smooth out trends, thus changes in individual mares were
overlooked.
Fecal progestins were 100 fold greater in concentration than plasma progestins
(Table 1), similarly to previous studies by Miller et al. (2000). Knowles et al. (1994)
supported the idea of total progestins increasing from 100 to 160 days of gestation.
Interestingly, the range of concentrations between progestins in plasma versus feces, as
depicted by Table 1, was anywhere from about 6 times the concentration of 20a-5ct in
feces than in plasma, to approximately 800 times the concentration in fecal-diol than
in plasma. According to Figure 1, log of total plasma and fecal progestins increased at a
relatively similar rate, indicating either plasma or feces could be analyzed to obtain
similar results, particularly in research with wild equids. Fecal samples would be ideal in
these studies, since sample collection is safe, easy, and less stressful on the animal than
blood collection. According to Miller and Holtan (1997), much higher concentrations
were detected and a greater number of different progestins were present in feces of ewes
than in the peripheral circulation, thus it would be ideal to utilize feces instead of plasma.
This trend would be applicable to certain progestins like 20a-5a, so further assays, such
as developed by Squires et al. (1986), can be manufactured to measure these in the field
to determine if placentation was successful.
According to Holtan et al. (1991), the differential in progestin quality and quantity
throughout pregnancy in equids is most likely represented by the difference between50
sources, increased 20a- and 2013-hydroxylation in the liver and gastrointestinal system,
different metabolic pathways in the feto-placental unit, and variability among progestins
and individual mares, as described by Hamon et al. (1991) and Chavatte et al. (1997).
Miller and Holtan (1997) found similar results stating the ewe placenta had a complex
metabolism as well. The most likely explanation for this phenomenon, as discussed by
Adlercreutz et al. (1979) in humans, is that intestinal microflora and mucosa alter the
activity, quantity, and excretion of progestins throughout gestation. However, more
research needs to be conducted in the mare to determine the exact mechanism.
Interactions of mare by sample and sample by day were not significant for total
progestins because over time and in individual mares, the trend for both plasma and feces
was to increase at a constant rate over time. This was not the case when individual
progestins were analyzed, as reported in Table 3. For example, compared to total
progestins, all progestins were significant regarding the mare by sample interaction. This
was so because plasma and fecal progestin concentrations differed among individual
mares.
Like the total progestins, 5a-DHP did not have a significant sample by day
interaction, since over time, plasma and fecal concentrations changed at a constant rate.
Progesterone (P4) was not significant regarding sample or day, because there was not
much difference in concentration between plasma and feces, and there was a constant rate
of change over time (Figure 2). Progestins P4, 33-5a, 3cx-5a, and 20a-5a were
significant in sample by day interaction, unlike the total progestins, because over time
there was a difference between plasma and fecal concentrations. These progestins
showed this relationship well in plots of log ratios (Figure 5).
Even though progestins were highly positively correlated in relation to the time
factor (full Pearson correlation) between plasma and feces, as described by Miller et al.
(2000) in ewes, they still changed at different rates over time. The only negative
correlation found was between plasma and fecal P4. This meant plasma P4 was
decreasing in concentration, while fecal P4 was increasing over time (Figure 2). The
reason plasma P4 decreased over time was due to decreased ovarian and CL function, as
described by Squires et al. (1974) and Ganjam and Kenney (1975). Other possibilities51
include differences in solubility in plasma or feces, sample stability, physiological
effects on metabolic routes, and bacterial action (Adlercreutz et al., 1979).
A partial Pearson correlation indicated none of the individual plasma and fecal
progestins were related to each other when the time factor was taken out, since daily
variation was such that no clear correlation was possible.
When log ratios were examined, compared to the increase observed in total
progestins over time, individual progestins showed three different rate patterns-increase,
decrease, or no change over time-caused by differences in steroidogenesis and
metabolism, as described by Holtan et al. (1991). This is important when choosing
specific progestin assays for diagnosing functional placentation, and whether to collect
plasma or feces depending on the rate of change of that particular progestin located in
that source. For example, 20a-5a would be ideal to analyze in plasma, since its
concentration in plasma increased much faster than in feces over time resulting in a
negative ratio (Figure SB).
Preliminary data by Miller and Holtan (1997) indicated fecal progestins increased
abruptly around day 80 of gestation, similarly to the study of urinary hormones increasing
visually around 90 days of pregnancy in mares. Marked increase was noted in E1S at 80
days of gestation, reaching maximal levels of 143.3 pg/mg Cr on day 142 of pregnancy.
Its maximum concentration was reached between 140 to 170 days of gestation, and then
decreased until parturition (Riad and Holtan, 1993). This study showed most progestins
were sharply increasing beyond 120 days of pregnancy due to the time factor and
increased fetal size, except for plasma P4. On the other hand, PdG remained stable until
80 days of gestation. Its profile paralleled blood values, as noted by Riad and Holtan
(1993). They determined the different patterns produced by the urinary hormones were
caused by the differences between source and metabolism in the feto-placental unit. The
sharp increase in PdG and El S thus reflected a mature, functional feto-placental unit.
This would probably be the case in our study. Observing a similar trend of increase in
progestins, such as 33-5a, 2Oct-5a, and ac-diol in both plasma and feces, would indicate
a mature placenta capable of maintaining pregnancy. Day of changeover from ovarian to
placental source of progestins, as represented by 3-5a, 20a-5a, 3-diol, anda-diol,52
varied significantly from the 90-day change point in the urinary hormones, PdG and
E1S (Riad and Holtan, 1993). The point of changeover for both plasma and fecal
progestins on average seemed to be around 111 days of gestation.
Spline regression indicated the mean day of increase in plasma for the four
progestins, 3-5a, 20a-5a,-diol, anda-diol, was 112.7, and day 109 in feces.
Plasma fEkx-diol and fecal 20a-5a matched the mean values the closest, although the other
two progestins were within this limit. Some spline regression values were unobtainable,
because this procedure only works on linear equations when there are different slopes
along the same lines. It is not effective on constant or curvilinear data, such as for fecal
3-diol and Ia-diol, which did not have a distinct change in the rate of increase, as
depicted by the plotted ratio (Figure 5C). Overall range for the mean day of increase for
the four progestins was from 110 to 115 days of pregnancy in plasma, while in feces the
range was from 108 to 110 days of gestation. This wide range was due to individual
progestin and mare variability, as well as differences in the metabolism of progestins, as
described by Ganjam et al. (1975), Adlercreutz et al. (1979), and Hamon et al. (1991).
The possible reason spline regression indicated a change point around 111 days of
gestation is because Allen (1982) and Steven (1982) stated that by day 100 of gestation,
primary viffi develop secondary branches marking a complex feto-maternal
interdigitation both at the macro- and microvillous level over the entire endometrial
surface. Anatomically, this would mean the placenta is fully functional, coinciding with
the time of increase and differentiation of progestins in this study due to increased
vascularization and interdigitation between fetal and maternal endocrine tissues.
When considering this project, an afterthought was to review studies dealing with
the question when is the mare fully capable of carrying a foal to term without ovarian or
Regu-Mate® support. Ginther (1985a) stated abortionwas less likely to occur after 60 to
75 days of pregnancy. If treatment is initiated without cause and no clear rationale for
treatment termination is available, this practice of supplemental progestin therapy is
expensive at best and most likely unnecessary at worst. Recent work suggests initiating
and continuing treatment until term (Rossdale et al., 1991). Knowles et al. (1994) later
suggested 100 days of gestation was the most appropriate time to stop treatment, as53
demonstrated by their previous studies (1993). Holtan et al. (1979) noted that if mares
were OVX between 140 to 210 days of gestation, fetuses were carried to term,
implicating ovaries were not needed at this stage to maintain pregnancy. Despite Regu-
Mate's® popularity and effectiveness, Allen (1982) found it tended to hasten the demise
of existing CL, and did not increase fetal survival rates. Although this study did not
perform similar studies, our data suggest stopping treatment around 110 to 120 days of
gestation, as reported by Discafani et al. (1995).
Individual Mare Results
There was quite a lot of variation, not only between mean progestin
concentrations and source, but also between individual mares, as reported by Hamon et
al. (1991). It was often difficult to determine points of change in individual mares and
progestins, as depicted by Figure 6. Individual mare variability among values could not
be compared to urinary data because only mean values were known.
Future Considerations
Future research, as summarized by Baumholtz (1998), needs to be conducted to
understand the unique hormonal profile of the pregnant mare, as well as to understand
source and biological activity of these different progestins. Increased knowledge will
help in practical applications, such as developing pregnancy or pregnancy problem
diagnostic tests, and developing hormonal treatment therapies for at-risk pregnancies as
in the study by Brown et al. (1994). Increased knowledge in this field could also have
effects on research in related fields or other species. Next step in this research would be
to add miniature horses and draft mares, since Hamon et al. (1991) noted there was
significant variation among different types and breeds of mares. Additionally, other
equids such as donkeys, mules, and zebras could be studied. This is a relatively newarea
of study in equine reproduction and opens up many options for research. Comparative54
studies between different species can be conducted to determine which progestins
function best in order to develop specific assays that detect successful placentation.
For further progestin profile studies, it would be necessary to do a 24-hour
progestin profile collecting plasma and fecal samples every half hour in several mares. In
this way, we would be able to determine the extent of progestin level fluctuation during
the day. This may explain why some progestins varied tremendously regarding
concentration on a daily basis.
GCIMS is not practical for fieldwork or routine sampling, but is more suited
toward research. Feces need to be extensively analyzed using GC/MS to determine all
the progestins present throughout the entire gestation in the mare. The study of fecal
progestins alone is far from clarified. Basic fecal progestin research with reference to
diet, anestrus, diestrus, estrus, transitional mares, levels during the entire gestation, and
other hormonal influences needs to be addressed before "mare side" tests of fecal
progestins will be of value. The other question that begs to be addressed is which of the
progestins identified in this study are mimicked or supplemented by the administration of
ReguMate.® Only thencan specific assays selective for specific progestins be developed
for routine sampling. Knowledge of which progestins change and specifically when
these changes occur during gestation would tremendously aid in the development and
interpretation of such immunoassays.55
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